NYSE:CHE - Chemed Stock Price, Forecast & News

Chemed trades on the New York Stock Exchange (NYSE) under the ticker symbol "CHE."

Chemed declared a quarterly dividend on Friday, November 1st. Stockholders of record on Monday, November 11th will be given a dividend of $0.32 per share on Monday, December 2nd. This represents a $1.28 annualized dividend and a dividend yield of 0.27%. The ex-dividend date is Thursday, November 7th. View Chemed's Dividend History.

Chemed announced that its Board of Directors has approved a stock repurchase plan on Wednesday, March 7th 2018, which permits the company to buyback $150,000,000.00 in outstanding shares, according to EventVestor. This buyback authorization permits the company to purchase shares of its stock through open market purchases. Stock buyback plans are usually an indication that the company's board believes its stock is undervalued.

Chemed Co. (NYSE:CHE) announced its earnings results on Tuesday, October, 29th. The company reported $3.46 EPS for the quarter, beating the Thomson Reuters' consensus estimate of $3.31 by $0.15. The company had revenue of $480.61 million for the quarter, compared to analyst estimates of $478.89 million. Chemed had a net margin of 11.14% and a return on equity of 35.06%. Chemed's revenue was up 8.2% on a year-over-year basis. During the same quarter in the previous year, the company posted $3.07 earnings per share. View Chemed's Earnings History.

Chemed is scheduled to release their next quarterly earnings announcement on Tuesday, February 18th 2020. View Earnings Estimates for Chemed.

Chemed will be holding an earnings conference call on Tuesday, February 18th at 12:00 AM Eastern. Interested parties can register for or listen to the call using this link or dial in at Not Available.

4 Wall Street analysts have issued twelve-month price targets for Chemed's stock. Their forecasts range from $405.00 to $500.00. On average, they expect Chemed's stock price to reach $466.25 in the next twelve months. This suggests that the stock has a possible downside of 3.2%. View Analyst Price Targets for Chemed.

4 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Chemed in the last year. There are currently 2 hold ratings and 2 buy ratings for the stock, resulting in a consensus recommendation of "Buy." View Analyst Ratings for Chemed.

Media coverage about CHE stock has been trending very positive recently, according to InfoTrie Sentiment. InfoTrie scores the sentiment of news coverage by monitoring more than six thousand news and blog sources. The firm ranks coverage of public companies on a scale of negative five to positive five, with scores nearest to five being the most favorable. Chemed earned a media sentiment score of 3.3 on InfoTrie's scale. They also gave news stories about the company a news buzz of 2.0 out of 10, indicating that recent news coverage is very unlikely to have an effect on the company's share price in the near term. View News Stories for Chemed.

Some companies that are related to Chemed include Laboratory Corp. of America (LH), Quest Diagnostics (DGX), Davita (DVA), Amedisys (AMED), LHC Group (LHCG), AMN Healthcare Services (AMN), BioScrip (BIOS), MEDNAX (MD), CorVel (CRVL), R1 RCM (RCM), Tivity Health (TVTY), The Providence Service (PRSC), Cross Country Healthcare (CCRN) and Interpace Diagnostics Group (IDXG).

Based on aggregate information from My MarketBeat watchlists, some companies that other Chemed investors own include Home Depot (HD), Altria Group (MO), AT&T (T), AbbVie (ABBV), CVS Health (CVS), Chevron (CVX), Walt Disney (DIS), Enterprise Products Partners (EPD), Occidental Petroleum (OXY) and Boeing (BA).

Chemed's stock is owned by many different of institutional and retail investors. Top institutional shareholders include Riverbridge Partners LLC (2.29%), Boston Trust Walden Corp (0.75%), Virginia Retirement Systems ET AL (0.55%), Retirement Systems of Alabama (0.26%), California Public Employees Retirement System (0.25%) and New York State Teachers Retirement System (0.17%). Company insiders that own Chemed stock include Andrea R Lindell, David Patrick Williams, Donald E Saunders, Frank E Wood, George J Walsh III, Kevin J Mcnamara, Michael D Witzeman, Naomi C Dallob, Nicholas Michael Westfall, Patrick P Grace, Spencer S Lee, Thomas P Rice and Walter L Krebs. View Institutional Ownership Trends for Chemed.

CHE stock was sold by a variety of institutional investors in the last quarter, including Riverbridge Partners LLC, W.E. Donoghue & Co. LLC, Dupont Capital Management Corp, Campbell & CO Investment Adviser LLC, Nisa Investment Advisors LLC, Arizona State Retirement System, NEXT Financial Group Inc and State of Alaska Department of Revenue. Company insiders that have sold Chemed company stock in the last year include Andrea R Lindell, David Patrick Williams, Donald E Saunders, Frank E Wood, George J Walsh III, Kevin J Mcnamara, Michael D Witzeman, Naomi C Dallob, Spencer S Lee, Thomas P Rice and Walter L Krebs. View Insider Buying and Selling for Chemed.

CHE stock was purchased by a variety of institutional investors in the last quarter, including Mckinley Capital Management LLC Delaware, First Quadrant L P CA, Boston Trust Walden Corp, SG Americas Securities LLC, Janney Montgomery Scott LLC, Strs Ohio, AE Wealth Management LLC and Calamos Advisors LLC. Company insiders that have bought Chemed stock in the last two years include Donald E Saunders and George J Walsh III. View Insider Buying and Selling for Chemed.

Shares of CHE can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity and Charles Schwab.

One share of CHE stock can currently be purchased for approximately $481.84.

Chemed has a market capitalization of $7.71 billion and generates $1.78 billion in revenue each year. The company earns $205.54 million in net income (profit) each year or $11.93 on an earnings per share basis. Chemed employs 15,707 workers across the globe.View Additional Information About Chemed.

The official website for Chemed is http://www.chemed.com/.

Chemed's mailing address is 255 EAST FIFTH STREET SUITE 2600, CINCINNATI OH, 45202. The company can be reached via phone at 513-762-6690.